FMR LLC - 31 Dec 2025 SCHEDULE 13G/A Report for JANUX THERAPEUTICS INC COMMON STOCK (JANX)

Filing Manager
FMR LLC
Reporting Manager
FMR LLC
Symbol
JANX
Shares outstanding
60,558,345 shares
Disclosed Ownership
3,512,384 shares
Ownership
5.8%
Form type
SCHEDULE 13G/A
Filing time
08 Jan 2026, 09:09:46 UTC
Date of event
31 Dec 2025

Sponsored

Quoteable Key Fact

"FMR LLC disclosed 5.8% ownership in JANUX THERAPEUTICS INC COMMON STOCK (JANX) on 31 Dec 2025."

Quick Takeaways

  • FMR LLC filed SCHEDULE 13G/A for JANUX THERAPEUTICS INC COMMON STOCK (JANX).
  • Disclosed ownership: 5.8%.
  • Date of event: 31 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 08 Jan 2026, 09:09.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
FMR LLC 5.8% 3,512,384 3,505,856 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Abigail P. Johnson 5.8% 3,512,384 0 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**